Syntheses and crystal structures of copper(II) and nickel(II) complexes derived from 2-bromo-4-chloro-6-[(2-methylaminoethylimino)methyl]phenol

A new centrosymmetric mononuclear copper(II) complex [Cu(L)₂](ClO₄)₂ (I) and a new centrosymmetric mononuclear nickel(II) complex [Ni(L)₂(MeOH)₂](ClO₄)₂ (II), where L is the zwitterionic ligand 2-bromo-4-chloro-6-[(2-methylammonioethylimino)methyl]phenolate, have been prepared from the Schiff base 2-bromo-4-chloro-6-[(2-methylaminoethylimino)methyl]phenol with copper perchlorate and nickel perchlorate, respectively. The complexes were characterized by elemental analysis, infrared spectra, and single-cyrstal X-ray diffraction (CIF files CCDC nos. 1408054 (I) and 1407973 (II)). Complex I crystallizes in the monoclinic space group P2₁/c with unit cell dimensions a = 7.7736(4), b = 21.608(1), c = 8.5194(4) Å, β = 93.907(2)°, V = 1427.7(1) ų, Z = 2, R ₁ = 0.0546, and wR ₂ = 0.1531. Complex II crystallizes in the monoclinic space group P2₁/c with unit cell dimensions a = 21.324(3), b = 16.821(2), c = 9.425(1) Å, β = 90.114(2)°, V = 3380.5(7) ų, Z = 4, R ₁ = 0.0693, and wR ₂ = 0.1627. The Cu atom in I is in square planar coordination, and the Ni atom in II is in octahedral coordination.     

Synthesis,crystal structures,and antibacterial activities of Schiff base nickel(II) and cadmium(II) complexes with tridentate Schiff bases

Reaction of tridentate Schiff bases with nickel and cadmium salts in methanol afforded two new mononuclear complexes, [Ni(L¹)₂] (I) and [Cd(L²)₂] (II), where L¹ and L² are the anions of 2-bromo-4-chloro-6-[(3-dimethylaminopropylimino)methyl]phenol (HL¹) and 2-bromo-4-chloro-6-[(3-morpholin-4-ylpropylimino)methyl]phenol (HL²), respectively. The complexes were characterized by singlecrystal X-ray diffraction (CIF files CCDC nos. 1428653 (I) and 1428654 for (II)), FT-IR, and elemental analysis. Complex I crystallizes in the monoclinic space group P2 ₁/c, with a = 8.8216(8), b = 14.0424(8), c = 11.8687(12) Å, β = 111.238(2)°, V = 1370.4(2) ų, Z = 2. Complex II crystallizes in the monoclinic space group P2 ₁/n, with a = 9.6774(4), b = 15.8970(6), c = 20.3144(7) Å, β = 90.408(2)°, V = 3125.1(2) ų, Z = 4. The metal atoms in the complexes are coordinated by two tridentate Schiff base ligands, forming octahedral coordination. The free Schiff bases and the complexes were assayed for antibacterial activities. Both complexes are more active against the bacteria than the free Schiff bases. Complex II has the MIC value of 0.39 μg mL^–1 against Bacillus subtilis.     

Synthesis and crystal structure of two derivatives of benzodiazepines

Two benzodiazepine derivatives, C₂₃H₂₂N₂O (I), 2-methyl-8-methoxy-2,4-diphenyl-2,3-dihydro-1H-1,5-benzodiazepine, and C₂₂H₁₇N₃O₂Br₂ (II), 2-methyl-7-nitro-2,4-bis(4′-bromophenyl)-2,3-dihydro-1H-1,5-benzodiazepine, were studied by single crystal X-ray diffraction method. Compound (I) crystallizes in the monoclinic system, space group P2₁/c, a = 13.1703(17) Å, b = 11.1990(14) Å, c = 12.9093(16) Å, β = 107.831(2)°, V = 1812.6(3) ų, Z = 4. Compound (II) crystallizes in the monoclinic system, space group P2₁/n, a = 11.7345(12) Å, b = 12.7477(13) Å, c = 13.5965(14) Å, β = 95.221(2)°, V = 2025.4(4) ų, Z = 4. The molecules of (I) and (II) have T-shape form with the diazepine ring at the junction point. The seven membered central benzodiazepine ring in both structures adopt a twist-boat conformation. The crystal packing is stabilized by C-H…π (in I) and C-H…O (in II) interactions.     

Synthesis,crystal structures,and antibacterial activities of Schiff base zinc(II) complexes [Zn(L<Superscript>1</Superscript>)<Subscript>2</Subscript>] and [Zn(L<Superscript>2</Superscript>)<Subscript>2</Subscript>]

The reaction of cyclopentylamine with 2-hydroxy-1-naphthaldehyde and 5-nitrosalicylaldehyde, respectively, in methanol affords two new Schiff bases, 1-(cyclopentyliminomethyl)naphthalen-2-ol (HL¹) and 4-nitro-2-(cyclopentyliminomethyl)phenol (HL²). Two new zinc(II) complexes, [Zn(L¹)₂] (I) and [Zn(L²)₂] (II), derived from the Schiff bases, have been prepared and characterized by single-crystal X-ray diffraction, FT-IR, and elemental analysis. Complex I crystallizes in the monoclinic space group P2₁/c with a = 17.834(4), b = 14.738(3), c = 9.868(2) Å, β = 91.20(3)°, V = 2593.1(9) ų, Z = 4. Complex II crystallizes in the triclinic space group P \(\bar 1\) with a = 10.206(1), b = 10.502(1), c = 12.554(1) Å, α = 66.771(2)°, β = 78.133(2)°, γ = 76.292(2)°, V = 1191.8(1) ų, Z = 2. The Zn atom in each complex is coordinated by two N and two O atoms from two Schiff base ligands, forming a tetrahedral geometry. The Schiff bases and the complexes were assayed for antibacterial activities.     

Synthesis and crystal structures of cobalt(III) and zinc(II) complexes with Schiff bases

Two new cobalt(III) and zinc(II) complexes, [Co(L¹)₂ (H₂O)] · ClO₄ (I) and [Ni(L²)₂ (H₂O)₂] · 2ClO₄ (II), where L¹ is the deprotonated form of 5-methoxy-2-[(2-morpholin-4-ylethylimino)methyl]phenol, and L² is the zwitterionic form of 2-[(2-isopropylaminoethylimino)methyl]-5-methoxyphenol, were synthesized and structurally characterized by elemental analyses, IR spectra, and single-crystal X-ray diffraction. The crystal of I is monoclinic: space group P2₁/c, a = 11.1512(4), b = 28.2424(11), c = 10.9655(4) Å, β = 95.746(2)°, V = 3436.1(2) ų, Z = 4. The crystal of II is triclinic: space group P2₁/c, a = 8.1441(2), b = 10.4531(3), c = 10.8849(3) Å, α = 84.0240(10)°, β = 76.9800(10)°, γ = 74.2280(10)°, V = 867.92(4) ų, Z = 1. Complex I consists of a mononuclear cobalt(III) complex cation and a perchlorate anion. Complex II consists of a crystallographic centrosymmetric mononuclear nickel(II) complex cation and two perchlorate anions. Each metal atom in the complexes is in an octahedral coordination.     

Synthesis and crystal structures of the nickel(II) complex with nitronyl nitroxide

Two nickel(II) complexes [Ni(NIT-l′-MeBzlrn)₂(Dca)₂] (I, II) (NIT-l′-MeBzIm = 2-{2′-[(l′methyl)benzimidazolyl]}-4,4,5,5-tetramethylimidazoline-l-oxyl-3-oxide) have been prepared and structurally characterized by single-crystal X-ray diffraction. They are structural epimers. The complexe crystallizes in monoclinic, space group P2₁/n, Z = 4. Crystal data: C₃₄H₃₈N₁₄NiO₄, M _r = 765.49, a = 15.019(3), b = 18.803(4), c = 15.756(3) Å, β = 109.399(3)°, γ = 90° (I); a = 13.934(3), b = 11.046(2), c = 24.570(5) Å, β = 90.024(2)° (II). The X-ray analysis reveals that Ni²⁺ ion resides in a distorted octahedral center. The complex was linked by intermolecular hydrogen bonds, resulting in a ID chain structure for I and a 2D network configuration for II.     

Synthesis and crystal structures of two zinc(II) complexes derived from 4-bromo-2-(cyclopentyliminomethyl)phenol with different solvents

Two new mononuclear zinc(II) complexes, [ZnL₂] (I) and [ZnL₂] · 2MeOH (II) (HL = 4-bromo-2-(cyclopentyliminomethyl)phenol), were synthesized by the reaction of the Schiff base HL with zinc acetate in ethanol and methanol solutions, respectively. Both complexes were characterized by elemental analyses and single-crystal X-ray diffraction. The crystal of I is orthorhombic: space group Pbca, a = 14.711(3), b = 13.223(3), c = 24.870(5) Å, V = 4837.8(18) ų, Z = 8. The crystal of II is monoclinic: space group C2/c, a = 20.581(5), b = 10.660(3), c = 15.428(4) Å, β = 119.919(3)°, V = 2933.7(13) ų, Z = 4. The Zn atom in each complex is four-coordinated by two imine N and two phenolic O atoms, forming a tetrahedral geometry. Complex II possesses crystallographic two-fold rotation axis symmetry.     

Structure and properties of the volatile isomers of bis(1,1,1-trifluoro-5,5-dimethylhexane-2,4-dionato) of platinum(II)

In the work, isomeric complexes of platinum(II) with the (ptac)^–1 pivaloyltrifluoroacetonate ion (Pt((CH₃)₃–CO–CH–CO–CF₃)₂) are studied. The synthesis and chromatographic separation of Pt(ptac)₂ isomers are described, TGA data for the separated isomers are given, and the crystal structures of the solid phases are studied. The cis-Pt(ptac)₂ complex crystallizes in the space group P-1, a = 10.7091(4) Å, b = 12.7787(6) Å, c = 16.0154(8) Å, α = 92.389(2)°, β = 90.868(2)°, γ = 112.1260(10)°, V = 2027.39(16) ų, Z = 4, d _calc = 1.918 g/cm³. The trans-Pt(ptac)₂ complex crystallizes in the space group C2/m, a = 13.3235(5) Å, b = 8.5515(3) Å, c = 9.6694(3) Å, β = 118.5880(10)°, V = 967.38(6) Å3, Z = 2, d _calc = 2.010 g/cm3. The structures of the complexes are molecular, the Pt atom has a square coordination of four oxygen atoms of two ligands; for cis-Pt(ptac)2, the Pt–Oav distance is 1.968 Å, for trans-Pt(ptac)2 it is 1.980 Å.     

Structural investigation of [Au(en)<Subscript>2</Subscript>]Cl(ReO<Subscript>4</Subscript>)<Subscript>2</Subscript> and [Au(en)<Subscript>2</Subscript>](ReO<Subscript>4</Subscript>)<Subscript>3</Subscript> complexes

Novel complex salts [Au(en)₂]Cl(ReO₄)₂ (I) and [Au(en)₂](ReO₄)₃ (II), en = ethylenediamine, are obtained. Their crystal structures are determined by single crystal X-ray diffraction. Complex I crystallizes in the triclinic crystal system: a = 6.2172(7) Å, b = 7.1644(8) Å, c = 8.8829(8) Å, α = 96.605(4)°, β = 110.000(4)°, γ = 97.802(4)°, P-1 space group, Z = 1, d _x = 3.905 g/cm³; complex II crystallizes in the monoclinic crystal system: a = 15.244(2) Å, b = 7.6809(8) Å, c = 9.3476(12) Å, β = 127.004(3)°, C2 space group, Z = 4, d _x = 4.057 g/cm³.     

Crystal structures of two new dinuclear Ag(I) complexes constructed from 4,4′-biphenyldicarboxylic acid and N-containing ligands

The reaction of silver 4,4′-biphenyldicarboxylate with 1,3-diaminopropane (DAP) and 2-amino-5-methylpyridine (AMP) respectively results in the formation of two dinuclear silver(I) complexes: [Ag₂(DAP)₂](BPC)·2H₂O (1) and [Ag₂(BPC)(AMP)₄]·2H₂O (2), where BPC is 4,4′-biphenyldicarboxylate. The complexes are characterized by elemental analysis and X-ray crystallography. Complex 1 crystallizes in the triclinic system, P-1 space group, a = 8.585(2) Å, b = 8.849(2) Å, c = 9.890(3) Å, α = 107.893(3)°, β = 94.139(3)°, γ = 113.202(3)°, V = 640.9(3) ų, Z = 1. Complex 2 crystallizes in the triclinic system, P-1 space group, a = 11.818(3) Å, b = 13.132(4) Å, c = 13.281(4) Å, α = 92.571(4)°, β = 96.425(3)°, γ = 102.142(4)°, V = 1997.5(10) ų, Z = 2. Complex 1 consists of a macrocyclic dinuclear silver(I) dication, a 4,4′-biphenyldicarboxylate anion, and two water molecules of crystallization. Each Ag atom is in a linear coordination. Complex 2 consists of a dinuclear silver(I) complex molecule and two water molecules of crystallization. Each Ag atom is in a T-shaped coordination. The Ag...Ag separations are 5.127(2) Å in 1 and 3.172(2) Å in 2.     

Synthesis,characterization, crystal structures,and antimicrobial activity of cobalt(II) and iron(III) complexes derived from N'-(2-hydroxybenzylidene)-3-methylbenzohydrazide

A new cobalt(II,III) complex, [Co^IIIL₂]₂[Co ₂ ^II (HL)₂(OH₂)₂(CH₃OH)₂] ? 2H₂O (I) and a new iron(III) complex, [Fe^III(HL)₂](NO₃) (II), where L^2– and HL^– are the dianionic and monoanionic form of N'-(2-hydroxybenzylidene)-3-methylbenzohydrazide, respectively, have been prepared and characterized by elemental analyses, infrared and UV-Vis spectroscopy and single-cyrstal X-ray diffraction (CIF files CCDC nos. 1417971 (I), 1417979 (II)). Complex I crystallizes in the monoclinic space group P2₁/n with unit cell dimensions a = 16.1665(9), b = 14.5692(8), c = 19.086(1) Å, β = 96.347(1)°, V = 4467.9(4) ų, Z = 2, R ₁ = 0.0521, and wR ₂ = 0.1411. Complex II crystallizes in the orthorhombic space group Pbcn with unit cell dimensions a = 12.475(1), b = 12.202(1), c = 18.859(2) Å, V = 2870.8(4) ų, Z = 4, R ₁ = 0.0796, and wR ₂ = 0.1981. The metal atoms in the complexes are in octahedral coordination. Crystals of the complexes are stabilized by hydrogen bonds. The efficiency of the aroylhydrazone and the two complexes was evaluated against B. subtilis, S. aureus, E. coli, P. fluorescence, C. albicans and A. niger, with the complexes demonstrating enhanced activity relatively to the free ligand.     

The crystal and molecular structure of Ni(II) complex with 1-(2-carboxyphenyl)-3-isopropyl-5-(benzimidazole-2-yl)formazane

The binuclear Ni(II) 1-(2-carboxyphenyl)-3-isopropyl-5-(benzimidazole-2-yl)formazanate (Ni₂L₂ · 2H₂O) (I) was synthesized and its crystal and molecule structures were determined by X-ray diffraction. Crystals I are triclinic: space group P \(\bar 1\), a = 7.4811(11), b = 10.8821(15), c = 11.4168(13) Å, α = 105.690(11) Å, β = 90.537(11) Å, γ = 93.166(11) Å, V = 893.2(2) ų, ρ(calcd.) = 1.581 g/cm³, Z = 1.     

Synthesis and structure investigation of Co(III) complex salts with the perrhenate anion

Complex salts of the composition [Co(NH₃)₆](ReO₄)₃·2H₂O (I), [Co(en)₃](ReO₄)₃ (II), [Co(NH₃)₅H₂O](ReO₄)₃·2H₂O (III), and [Co(NH₃)₅Cl](ReO₄)₂·0.5H₂O (IV) are obtained. Their crystal structures are determined by single crystal XRD. Crystallographic characteristics: (I) a = 9.9797(3) Å, b = 12.6994(3) Å, c = 14.7415(4) Å, β = 102.870(1)°, C2/c space group; (II) a = 8.0615(3) Å, b = 8.4483(4) Å c = 8.8267(4) Å, α = 61.923(2)°, β = 89.552(2)°, γ = 72.295(2)°, P1 space group; (III) a = 8.0086(4) Å, b = 12.9839(6) Å, c = 17.5122(7) Å, β=91.858(1)°, P2₁/n space group; (IV) a = 14.9446(3) Å, b = 14.6562(4) Å, c = 12.2434(4) Å, Cmc2₁ space group.     

Synthesis and crystal structures of two Schiff base copper(II) complexes derived from 4-chloro-2-[(2-morpholin-4-ylethylimino)methyl]phenol

A centrosymmetric mononuclear copper(II) complex, [Cu(L¹)₂] (I), and a phenolate oxygen-bridged dinuclear copper(II) complex, [Cu₂(L²)₄] (II) (HL¹ = 4-chloro-2-[(2-morpholin-4-ylethylimino)methyl]phenol, HL² = 4-chloro-2-(cyclohexylimino-methyl)phenol), were synthesized and characterized by elemental analyses, IR, and single crystal X-ray diffraction. The crystal of I is monoclinic: space group {ITP}2₁/n, a = 13.396(3), b = 5.339(1), c = 19.740(4) Å, β = 108.64(3), V = 1337.8(5) ų, {ITZ} = 2. The crystal of II is monoclinic: space group P2₁, a = 9.157(2), b = 22.715(4), c = 12.169(2) Å, = 95.28(3), {ITV} = 2520.4(8) Å3, {ITZ}= 2. The Cu atom in I, lying on the inversion center, is four-coordinate in a square planar geometry with two phenolate oxygen and two imine nitrogen atoms. Each Cu atom in II is five-coordinate in a square pyramidal geometry with two phenolate oxygen and two imine nitrogen atoms from two L² ligands defining the basal plane and with one phenolate oxygen atom of another L² ligand occupying the apical position.     

Synthesis and crystal structure of a new Schiff base ligand and its cobalt(II) complex

The crystal structures of cobalt(II) Schiff base complex (Co^IIL₂ · H₂O) and Schiff base ligand 3,5-dichlorosalicylidene-2-chlorophenylmethylamine (HL) have been determined by single-crystal X-ray analysis. The geometry around cobalt in Co^IIL₂ · H₂O is distorted tetrahedral. Co^IIL₂ · H₂O crystallizes in the monoclinic system, in space group C2/c, with crystallographic parameters: a = 12.9143(16) Å, b = 8.8326(16) Å, c = 25.115(3) Å, β = 92.791(10)°, V = 2861.4(7) ų, Z = 4, F(000) = 1420, and the final R indices (I > 2σ(I)) are R ₁ = 0.0440, wR ₂ = 0.1272. HL crystallizes in the monoclinic system, in space group P2₁/c, with crystallographic parameters: a = 11.9764(15), b = 8.2331(10), c = 14.2211(17) Å, β = 98.723(6)°, V = 1386.0(3) ų, Z = 4, F(000) = 640, and the final R indices (I > 2σ(I)) are R ₁ = 0.0397, wR ₂ = 0.1018.     

Syntheses,characterization, crystal structures and fluorescence property of Zinc(II) complexes with Schiff bases

Two new mononuclear Schiff base zinc(II) complexes, [ZnCl₂(L¹)] ? MeOH (I) and [Zn(L²)₂] (II) (L¹ = 2-bromo-4-chloro-6-[(2-ethylammonioethylimino)methyl]phenolate; L² = 2-bromo-4-chloro-6-(isopropyliminomethyl)phenolate), have been prepared and characterized by elemental analyses, infrared and UV-Vis spectroscopy, and single-cyrstal X-ray diffraction (CIF files CCDC nos. 1408962 (I), 1408961 (II)). Complex I crystallizes in the triclinic space group \(P\overline 1\) with unit cell dimensions a = 9.859(1), b = 13.015(2), c = 19.817(3) Å, α = 73.591(2)°, β = 76.032(2)°, γ = 82.966(2)°, V = 2363.0(5) ų, Z = 4, R ₁ = 0.0925, and wR ₂ = 0.2257. Complex II crystallizes in the monoclinic space group P2₁/c with unit cell dimensions a = 7.6387(7), b = 22.307(2), c = 21.443(2) Å, β = 96.216(3)°, V = 3632.4(6) ų, Z = 8, R ₁ = 0.0651, and wR ₂ = 0.1100. The both Zn atoms in I is four-coordinated in a tetrahedral geometry by the NO donor set of the Schiff base ligand, and two Cl ligands. The Zn atom in II is in a tetrahedral geometry by two N and two O atoms from two Schiff base ligands. Crystals of the complexes are stabilized by hydrogen bonds and weak π…π interactions. Fluorescence property of the complexes have been determined.     

Synthesis,crystal structures,and characterization of a new substituted 1,2,4-triazole and its two Co(II)/Mn(II) complexes

A new triazole-substituted ligand H₂L (H₂Trza = 3-amino-1H-1,2,4-triazole-5-acetate) and its two new isomorphic compounds [M(HTrza)₂(_H2O)₂] ? 2H₂O (Co(I) and Mn(II)) have been synthesized and characterized structurally. Their X-ray crystal structures (CIF files CCDC nos. 906893 for I and 906892 for II) show that H₂L belongs to a tetragonal system; space group P4₃ with a = b = 5.0445(13), c = 27.054(10) Å; Z = 4. Complex I belongs to a monoclinic system; space group P2₁/n with a = 7.6543(8), b = 7.3453(8), c = 13.6283(14) Å; β = 91.5990(10)°, Z = 2. Complex II belongs to a triclinic system; space group with a = 6.8550(15), b = 8.0630(18), c = 15.173(4) Å; α = 84.794(4)°, β = 79.005(3)°, γ = 73.779(4)°, Z = 2. X-ray analysis demonstrates that compound H₂L is found to contain a H₂Trza and a lattic water molecule; complexes I and II are discrete mononuclear species. The central Co(II) and Mn(II) atoms exhibit octahedral coordinations, type 4 + 2. In two compounds, the coordination entities are further organized via hydrogenbonding interactions to generate uniform supramolecular networks. Thermal stabilities of two compounds were examined by thermogravimetric analysis.     

Synthesis and crystal structure of two complexes [Cu<Subscript>2</Subscript>(NiL)<Subscript>2</Subscript>Cl<Subscript>4</Subscript>] and [Cd<Subscript>2</Subscript>(CuL)<Subscript>2</Subscript>Cl<Subscript>4</Subscript>]

Macrocyclic and supermolecular complexes [Cu₂(NiL)₂Cl₄] (I) and [Cd₂(CuL)₂Cl₄] (II) (H₂L = 2,3-dioxo-5,6,14,15-dibenzo-1,4,8,12-tetraazacyclo-pentadeca-7,13-diene) have been synthesized and structurally determined by X-ray diffraction and IR spectrum. Complex I crystallizes in the monoclinic system with P2₁/n group, a = 10.9019(15), b = 14.3589(19), c = 12.4748(17) 0A, β = 108.645(2)°, Z = 4. Complex II crystallizes in the monoclinic system with P2₁/n group, a = 10.9784(16), b = 14.580(2), c = 12.8904(18) Å, β = 109.339(2)°, Z = 4.     

Crystal structures of SrLnCuS<Subscript>3</Subscript> (Ln = Gd,Lu)

The crystal-chemical characteristics of new complex sulfides SrLnCuS₃ (Ln = Gd, Lu) are determined from the data of X-ray powder diffraction patterns. SrGdCuS₃ crystallizes in the orthorhombic crystal system (space group Pnma) and belongs to the Eu₂CuS₃ structure type with the unit cell parameters a = 10.3282(8) Å, b = 3.9624(2) Å, and c = 12.9364(9) Å. The structure of SrLuCuS₃ is orthorhombic: the KZrCuS₃ structure type, space group Cmcm, and unit cell parameters are a = 3.9105(2) Å, b = 12.9419(9) Å, and c = 10.0191(8) Å. A substantial role of crystal-chemical contraction inside the [LnCuS₃] dimeric block in the stabilization of structure types based on Eu₂CuS₃ and KZrCuS₃ is shown.     

Synthesis and crystal structures of two silver(I) complexes derived from 2-amino-6-methylpyridine with nicotinic acid and isonicotinic acid

The reaction of Ag₂O and 2-amino-6-methylpyridine (AMP) with nicotinic acid (HNA) and isonicotinic acid (HINA), respectively, afforded two silver(I) complexes, [Ag₂(NA)₂(AMP)₂] _n (I) and [Ag₂(INA)₂(AMP)₂] _n (II). Both complexes were characterized by elemental analyses and X-ray single-crystal diffraction. Complex I is a pyridine-3-carboxylate bridged polynuclear silver(I) complex, in which the Ag atom is in a tetrahedral geometry, while complex II is a pyridine-4-carboxylate bridged polynuclear silver(I) complex, in which the Ag atom is in a distorted T-shaped geometry. The crystal of I is monoclinic: space group P2₁/c, a = 8.079(2), b = 17.150(3), c = 8.912(2) Å, β = 98.106(2)°, V = 1222.5(5) ų, Z = 4. The crystal of II is monoclinic: space group P2₁/c, a = 7.225(1), b = 12.049(1), c = 15.053(2) Å, β = 102.050(1)°, V = 1281.6(3) ų, Z = 4.